Advertisement
Journal of Clinical Oncology  
Search for:
Limit by:
  Browse by Subject or Issue
Home Search or Browse JCO My JCO Subscriptions Customer Service Site Map

This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Save to my personal folders
Right arrow Download to citation manager
Right arrowRights & Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Simes, R. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Simes, R. J.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Journal of Clinical Oncology, Vol 4, 1529-1541, Copyright © 1986 by American Society of Clinical Oncology


ARTICLES

Publication bias: the case for an international registry of clinical trials

RJ Simes

A problem in evaluating different therapies from a review of clinical trials is that the published clinical trial literature may be biased in favor of positive or promising results. In this report, a model is proposed for reviewing clinical trial results which is free from publication bias based on the selection of trials registered in advance in a registry. The value of a registry is illustrated by comparing a review of published clinical trials located by a literature search with a review of registered trials contained in a cancer trials registry. Two therapeutic questions are examined: the survival impact of initial alkylating agent (AA) v combination chemotherapy (CC) in advanced ovarian cancer, and the survival impact of AA/prednisone v CC in multiple myeloma. In advanced ovarian cancer, a pooled analysis of published clinical trials demonstrates a significant survival advantage for combination chemotherapy (median survival ratio of CC to AA, 1.16; P = .02). However, no significant difference in survival is demonstrated based on a pooled analysis of registered trials (median survival ratio, 1.05; P = .25). For multiple myeloma, a pooled analysis of published trials also demonstrates a significant survival advantage for CC (median survival ratio, 1.26; P = 04), especially for poor risk patients (ratio, 1.66; P = .002). A pooled analysis of registered trials also shows a survival benefit for patients receiving combination chemotherapy (all patients, P = .06; poor risk, P = .03), but the estimated magnitude of the benefit is reduced (all patients: ratio, 1.11; poor risk: ratio, 1.22). These examples illustrate an approach to reviewing the clinical trial literature, which is free from publication bias, and demonstrate the value and importance of an international registry of all clinical trials.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
JAMAHome page
S. Mathieu, I. Boutron, D. Moher, D. G. Altman, and P. Ravaud
Comparison of Registered and Published Primary Outcomes in Randomized Controlled Trials
JAMA, September 2, 2009; 302(9): 977 - 984.
[Abstract] [Full Text] [PDF]


Home page
Arch. Dis. Child.Home page
C. Pandolfini, M. Bonati, and H. M Sammons
Registration of trials in children: update of current international initiatives
Arch. Dis. Child., September 1, 2009; 94(9): 717 - 719.
[Full Text] [PDF]


Home page
Hum ReprodHome page
S.-W. Guo, L. Hummelshoj, D. L. Olive, S. E. Bulun, T. M. D'Hooghe, and J. L.H. Evers
A call for more transparency of registered clinical trials on endometriosis
Hum. Reprod., June 1, 2009; 24(6): 1247 - 1254.
[Abstract] [Full Text] [PDF]


Home page
The OncologistHome page
S. Ramsey and J. Scoggins
Commentary: Practicing on the Tip of an Information Iceberg? Evidence of Underpublication of Registered Clinical Trials in Oncology
Oncologist, September 1, 2008; 13(9): 925 - 929.
[Abstract] [Full Text] [PDF]


Home page
The OncologistHome page
J. H. Doroshow
Commentary: Publishing Cancer Clinical Trial Results: A Scientific and Ethical Imperative
Oncologist, September 1, 2008; 13(9): 930 - 932.
[Full Text] [PDF]


Home page
JBJSHome page
K. Okike, M. S. Kocher, C. T. Mehlman, J. D. Heckman, and M. Bhandari
Publication Bias in Orthopaedic Research: An Analysis of Scientific Factors Associated with Publication in The Journal of Bone and Joint Surgery (American Volume)
J. Bone Joint Surg. Am., March 1, 2008; 90(3): 595 - 601.
[Abstract] [Full Text] [PDF]


Home page
ANN INTERN MEDHome page
C. Laine, C. De Angelis, T. Delamothe, J. M. Drazen, F. A. Frizelle, C. Haug, P. C. Hebert, R. Horton, S. Kotzin, A. Marusic, et al.
Clinical Trial Registration: Looking Back and Moving Ahead
Ann Intern Med, August 21, 2007; 147(4): 275 - 277.
[Full Text] [PDF]


Home page
JCOHome page
S. Bonovas, K. Filioussi, C. S. Flordellis, and N. M. Sitaras
Statins and the Risk of Colorectal Cancer: A Meta-Analysis of 18 Studies Involving More Than 1.5 Million Patients
J. Clin. Oncol., August 10, 2007; 25(23): 3462 - 3468.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
C. Laine, R. Horton, C. D. DeAngelis, J. M. Drazen, F. A. Frizelle, F. Godlee, C. Haug, P. C. Hebert, S. Kotzin, A. Marusic, et al.
Clinical Trial Registration: Looking Back and Moving Ahead
JAMA, July 4, 2007; 298(1): 93 - 94.
[Full Text] [PDF]


Home page
CMAJHome page
C. Laine MD MPH, R. Horton FMedSci, C. D. DeAngelis MD MPH, J. M. Drazen MD, F. A. Frizelle MBChB MMed, F. Godlee MBBChir BS, C. Haug MD PhD MSc, P. C. Hebert MD MHSc, S. Kotzin MLS, A. Marusic MD PhD, et al.
Clinical trial registration: looking back and moving ahead
Can. Med. Assoc. J., July 3, 2007; 177(1): 57 - 58.
[Full Text] [PDF]


Home page
NEJMHome page
C. Laine, R. Horton, C. D. DeAngelis, J. M. Drazen, F. A. Frizelle, F. Godlee, C. Haug, P. C. Hebert, S. Kotzin, A. Marusic, et al.
Clinical Trial Registration -- Looking Back and Moving Ahead
N. Engl. J. Med., June 28, 2007; 356(26): 2734 - 2736.
[Full Text] [PDF]


Home page
BMJHome page
C. Laine, R. Horton, C. D DeAngelis, J. M Drazen, F. A Frizelle, F. Godlee, C. Haug, P. C Hebert, S. Kotzin, A. Marusic, et al.
Clinical trial registration
BMJ, June 9, 2007; 334(7605): 1177 - 1178.
[Full Text] [PDF]


Home page
JAMAHome page
D. A. Zarin, N. C. Ide, T. Tse, W. R. Harlan, J. C. West, and D. A. B. Lindberg
Issues in the Registration of Clinical Trials
JAMA, May 16, 2007; 297(19): 2112 - 2120.
[Abstract] [Full Text] [PDF]


Home page
CMAJHome page
S. Bonovas and N. M. Sitaras
Does pravastatin promote cancer in elderly patients? A meta-analysis
Can. Med. Assoc. J., February 27, 2007; 176(5): 649 - 654.
[Abstract] [Full Text] [PDF]


Home page
Tobacco ControlHome page
L A Bero
Clinical trial registration at Tobacco Control
Tob. Control, December 1, 2006; 15(6): 417 - 418.
[Full Text] [PDF]


Home page
JCOHome page
S. Bonovas, K. Filioussi, N. Tsavaris, and N. M. Sitaras
Statins and Cancer Risk: A Literature-Based Meta-Analysis and Meta-Regression Analysis of 35 Randomized Controlled Trials
J. Clin. Oncol., October 20, 2006; 24(30): 4808 - 4817.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
D. S. Liebeskind, C. S. Kidwell, J. W. Sayre, and J. L. Saver
Evidence of publication bias in reporting acute stroke clinical trials.
Neurology, September 26, 2006; 67(6): 973 - 979.
[Abstract] [Full Text] [PDF]


Home page
JRSMHome page
I. Chalmers
From optimism to disillusion about commitment to transparency in the medico-industrial complex
J R Soc Med, July 1, 2006; 99(7): 337 - 341.
[Full Text] [PDF]


Home page
NEJMHome page
C. Haug, P. C. Gotzsche, and T. V. Schroeder
Registries and Registration of Clinical Trials
N. Engl. J. Med., December 29, 2005; 353(26): 2811 - 2812.
[Full Text] [PDF]


Home page
JCOHome page
S. Bonovas, K. Filioussi, N. Tsavaris, and N. M. Sitaras
Use of Statins and Breast Cancer: A Meta-Analysis of Seven Randomized Clinical Trials and Nine Observational Studies
J. Clin. Oncol., December 1, 2005; 23(34): 8606 - 8612.
[Abstract] [Full Text] [PDF]


Home page
BMJHome page
E. Decullier, V. Lheritier, and F. Chapuis
Fate of biomedical research protocols and publication bias in France: retrospective cohort study
BMJ, July 2, 2005; 331(7507): 19.
[Abstract] [Full Text] [PDF]


Home page
ANN INTERN MEDHome page
L. Hartling, F. A. McAlister, B. H. Rowe, J. Ezekowitz, C. Friesen, and T. P. Klassen
Challenges in Systematic Reviews of Therapeutic Devices and Procedures
Ann Intern Med, June 21, 2005; 142(12_Part_2): 1100 - 1111.
[Abstract] [Full Text] [PDF]


Home page
CMAJHome page
M. Bonati, C. Pandolfini, and On behalf of the DEC-net Collaborative Group
Pediatric clinical trials registry
Can. Med. Assoc. J., April 26, 2005; 172(9): 1159 - 1160.
[Full Text] [PDF]


Home page
Clin TrialsHome page
K. Dickersin, B. R Davis, D. O Dixon, S. L George, B. S Hawkins, J. Lachin, P. Peduzzig, and S. Pocock
The Society for Clinical Trials supports United States legislation mandating trials registration
Clinical Trials, October 1, 2004; 1(5): 417 - 420.
[Abstract] [PDF]


Home page
Arch Pediatr Adolesc MedHome page
L. Hartling, W. R. Craig, K. Russell, K. Stevens, and T. P. Klassen
Factors Influencing the Publication of Randomized Controlled Trials in Child Health Research
Arch Pediatr Adolesc Med, October 1, 2004; 158(10): 983 - 987.
[Abstract] [Full Text] [PDF]


Home page
Arch Pediatr Adolesc MedHome page
M. D. Dowd
Breaching the Contract: The Ethics of Nonpublication of Research Studies
Arch Pediatr Adolesc Med, October 1, 2004; 158(10): 1014 - 1015.
[Full Text] [PDF]


Home page
CMAJHome page
D. Moher and A. Bernstein
Registering CIHR-funded randomized controlled trials: a global public good
Can. Med. Assoc. J., September 28, 2004; 171(7): 750 - 751.
[Full Text] [PDF]


Home page
BMJHome page
K. Abbasi
Compulsory registration of clinical trials
BMJ, September 18, 2004; 329(7467): 637 - 638.
[Full Text] [PDF]


Home page
ChestHome page
M. L. Edmonds, B. H. Rowe, A. K. Nakanishi, and B. Rubin
Treatment With Inhaled Flunisolide
Chest, May 1, 2004; 125(5): 1961 - 1963.
[Full Text] [PDF]


Home page
JAMAHome page
B. Als-Nielsen, W. Chen, C. Gluud, and L. L. Kjaergard
Association of Funding and Conclusions in Randomized Drug Trials: A Reflection of Treatment Effect or Adverse Events?
JAMA, August 20, 2003; 290(7): 921 - 928.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
M. K. Krzyzanowska, M. Pintilie, and I. F. Tannock
Factors Associated With Failure to Publish Large Randomized Trials Presented at an Oncology Meeting
JAMA, July 23, 2003; 290(4): 495 - 501.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
K. Dickersin and D. Rennie
Registering Clinical Trials
JAMA, July 23, 2003; 290(4): 516 - 523.
[Abstract] [Full Text] [PDF]


Home page
BMJHome page
J. Lexchin, L. A Bero, B. Djulbegovic, and O. Clark
Pharmaceutical industry sponsorship and research outcome and quality: systematic review
BMJ, May 29, 2003; 326(7400): 1167 - 1170.
[Abstract] [Full Text] [PDF]


Home page
BMJHome page
H. Melander, J. Ahlqvist-Rastad, G. Meijer, and B. Beermann
Evidence b(i)ased medicine--selective reporting from studies sponsored by pharmaceutical industry: review of studies in new drug applications
BMJ, May 29, 2003; 326(7400): 1171 - 1173.
[Abstract] [Full Text] [PDF]


Home page
Arch Pediatr Adolesc MedHome page
T. P. Klassen, N. Wiebe, K. Russell, K. Stevens, L. Hartling, W. R. Craig, and D. Moher
Abstracts of Randomized Controlled Trials Presented at the Society for Pediatric Research Meeting: An Example of Publication Bias
Arch Pediatr Adolesc Med, May 1, 2002; 156(5): 474 - 479.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
G. P. Browman
Development and Aftercare of Clinical Guidelines: The Balance Between Rigor and Pragmatism
JAMA, September 26, 2001; 286(12): 1509 - 1511.
[Full Text] [PDF]


Home page
Clin. Chem.Home page
M. J. McQueen
Overview of Evidence-based Medicine: Challenges for Evidence-based Laboratory Medicine
Clin. Chem., August 1, 2001; 47(8): 1536 - 1546.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
I. F. Tannock
Commentary on ""Cytoreduction Nephrectomy in Metastatic Renal Cancer: The Results of Southwest Oncology Group Trial 8949""
J. Clin. Oncol., November 1, 2000; 18(90001): 39s - 42.
[Full Text] [PDF]


Home page
ANN INTERN MEDHome page
A. T. McCray
Better Access to Information about Clinical Trials
Ann Intern Med, October 17, 2000; 133(8): 609 - 614.
[Abstract] [Full Text] [PDF]


Home page
Med Decis MakingHome page
I. Sim, D. K. Owens, P. W. Lavori, and G. D. Rennels
Electronic Trial Banks: A Complementary Method for Reporting Randomized Trials
Med Decis Making, October 1, 2000; 20(4): 440 - 450.
[Abstract] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
P. G. Shields
Publication Bias Is a Scientific Problem with Adverse Ethical Outcomes: The Case for a Section for Null Results
Cancer Epidemiol. Biomarkers Prev., August 1, 2000; 9(8): 771 - 772.
[Full Text]


Home page
Postgrad. Med. J.Home page
R R WEST
Evidence based medicine overviews, bulletins, guidelines, and the new consensus
Postgrad. Med. J., July 1, 2000; 76(897): 383 - 389.
[Full Text]


Home page
BMJHome page
A. Tonks
Registering clinical trials
BMJ, December 11, 1999; 319(7224): 1565 - 1568.
[Full Text]


Home page
JAMAHome page
D. Rennie
Fair Conduct and Fair Reporting of Clinical Trials
JAMA, November 10, 1999; 282(18): 1766 - 1768.
[Full Text] [PDF]


Home page
BMJHome page
R. Horton and R. Smith
Time to register randomised trials
BMJ, October 2, 1999; 319(7214): 865 - 866.
[Full Text]


Home page
JCOHome page
M. Buyse, R. W. Carlson, P. Piedbois, R. Fossati, C. Confalonieri, V. Torri, and A. Liberati
Meta-Analyses of Published Results Are Unreliable
J. Clin. Oncol., May 1, 1999; 17(5): 1644 - 1644.
[Full Text] [PDF]


Home page
JAMAHome page
J. A. Berlin and G. A. Colditz
The Role of Meta-analysis in the Regulatory Process for Foods, Drugs, and Devices
JAMA, March 3, 1999; 281(9): 830 - 834.
[Abstract] [Full Text] [PDF]


Home page
Health Education JournalHome page
G. Peersman, A. Harden, S. Oliver, and A. Oakley
Discrepancies in findings from effectiveness reviews: the case of health promotion interventions to change cholesterol levels
Health Education Journal, January 1, 1999; 58(2): 192 - 202.
[Abstract] [PDF]


Home page
Nutr Clin PractHome page
R. L. Koretz
The Reading Corner. III. Error Types
Nutr Clin Pract, August 1, 1998; 13(4): 182 - 185.
[PDF]


Home page
JAMAHome page
A. L. Misakian and L. A. Bero
Publication Bias and Research on Passive Smoking: Comparison of Published and Unpublished Studies
JAMA, July 15, 1998; 280(3): 250 - 253.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
M. L. Callaham, R. L. Wears, E. J. Weber, C. Barton, and G. Young
Positive-Outcome Bias and Other Limitations in the Outcome of Research Abstracts Submitted to a Scientific Meeting
JAMA, July 15, 1998; 280(3): 254 - 257.
[Abstract] [Full Text] [PDF]


Home page
BMJHome page
J L Tang, J M Armitage, T Lancaster, C A Silagy, G H Fowler, H A W Neil, G. D. Smith, and S. Ebrahim
Systematic review of dietary intervention trials to lower blood total cholesterol in free-living subjects • Commentary: Dietary change, cholesterol reduction, and the public health---what does meta-analysis add?
BMJ, April 18, 1998; 316(7139): 1213 - 1220.
[Abstract] [Full Text]


Home page
JAMAHome page
J. P. A. Ioannidis
Effect of the Statistical Significance of Results on the Time to Completion and Publication of Randomized Efficacy Trials
JAMA, January 28, 1998; 279(4): 281 - 286.
[Abstract] [Full Text] [PDF]


Home page
BMJHome page
J. Savulescu, I. Chalmers, and J. Blunt
Are research ethics committees behaving unethically? Some suggestions for improving performance and accountability
BMJ, November 30, 1996; 313(7069): 1390 - 1393.
[Full Text]


Home page
JAMAHome page
L. Bero and D. Rennie
The Cochrane Collaboration: Preparing, Maintaining, and Disseminating Systematic Reviews of the Effects of Health Care
JAMA, December 27, 1995; 274(24): 1935 - 1938.
[Abstract] [PDF]


Home page
BMJHome page
M. Clarke and L. Greaves
Identifying relevant studies for systematic reviews
BMJ, March 18, 1995; 310(6981): 741a - 741.
[Full Text]


Home page
BMJHome page
C. E Counsell, M. J Clarke, J. Slattery, and P. A G Sandercock
The miracle of DICE therapy for acute stroke: fact or fictional product of subgroup analysis?
BMJ, December 24, 1994; 309(6970): 1677 - 1681.
[Abstract] [Full Text]


Home page
BMJHome page
M J Clarke and L A Stewart
Systematic Reviews: Obtaining data from randomised controlled trials: how much do we need for reliable and informative meta-analyses?
BMJ, October 15, 1994; 309(6960): 1007 - 1010.
[Full Text]


Home page
BMJHome page
Antiplatelet Trialists
Collaborative overview of randomised trials of antiplatelet therapy Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients
BMJ, January 8, 1994; 308(6921): 81 - 106.
[Abstract] [Full Text]


Home page
Stat Methods Med ResHome page
T. C. Harvard and J. Lau
Meta-analytic stimulus for changes in clinical trials
Statistical Methods in Medical Research, August 1, 1993; 2(2): 161 - 172.
[Abstract] [PDF]


Home page
JAMAHome page
D. J. Cook, G. H. Guyatt, G. Ryan, J. Clifton, L. Buckingham, A. Willan, W. Mcllroy, and A. D. Oxman
Should Unpublished Data Be Included in Meta-analyses? Current Convictions and Controversies
JAMA, June 2, 1993; 269(21): 2749 - 2753.
[Abstract] [PDF]


Home page
Arch Intern MedHome page
R. C. Brownson, T. E. Novotny, and M. C. Perry
Cigarette Smoking and Adult Leukemia: A Meta-analysis
Arch Intern Med, February 22, 1993; 153(4): 469 - 475.
[Abstract] [PDF]


Home page
JAMAHome page
D. Rennie and A. Flanagin
Publication Bias: The Triumph of Hope Over Experience
JAMA, January 15, 1992; 267(3): 411 - 412.
[Abstract] [PDF]


Home page
JAMAHome page
K. Dickersin
The Existence of Publication Bias and Risk Factors for Its Occurrence
JAMA, March 9, 1990; 263(10): 1385 - 1389.
[Abstract] [PDF]


Home page
JAMAHome page
l. Chalmers
Underreporting Research Is Scientific Misconduct
JAMA, March 9, 1990; 263(10): 1405 - 1408.
[Abstract] [PDF]


Home page
Arch Intern MedHome page
Y.-H. Chen and M. C. Magalhaes
Hypoalbuminemia in Patients With Multiple Myeloma
Arch Intern Med, March 1, 1990; 150(3): 605 - 610.
[Abstract] [PDF]


Home page
JAMAHome page
M. P. Longnecker, J. A. Berlin, M. J. Orza, and T. C. Chalmers
A Meta-analysis of Alcohol Consumption in Relation to Risk of Breast Cancer
JAMA, August 5, 1988; 260(5): 652 - 656.
[Abstract] [PDF]


Home page
JAMAHome page
M. Buyse, A. Zeleniuch-Jacquotte, and T. C. Chalmers
Adjuvant Therapy of Colorectal Cancer: Why We Still Don't Know
JAMA, June 24, 1988; 259(24): 3571 - 3578.
[Abstract] [PDF]



About
JCO
 Editorial
Roster
 Advertising
Information
 Librarians &
Institutions
 Rights &
Permissions
 PDA Services

Copyright © 1986 by the American Society of Clinical Oncology, Online ISSN: 1527-7755. Print ISSN: 0732-183X
Terms and Conditions of Use
  HighWire Press HighWire Press™ assists in the publication of JCO Online